High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer

High MeCo is predictive of poor outcomes in HER2-negative early breast cancer, although this risk can be mitigated by nintedanib, which is able to specifically reduce MeCo.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2024-09-16
DOI
https://doi.org/10.1158/1078-0432.ccr-24-1518
Citations
12
Primary Topic
Cellular Mechanics and Interactions
Type
article
Field-Weighted Citation Impact
3.91

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer

Miguel Quintela-Fandiño, Ghassan Mouneimne, Denise J. Roe, Begoña Bermejo et al.
12 citations
Clinical Cancer Research
Cellular Mechanics and Interactions
3.91
article

High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer

Miguel Quintela-Fandiño, Ghassan Mouneimne, Denise J. Roe, Begoña Bermejo, Adam Watson, Gemma Viñas, Sònia Pernas, José Á. García-Sáenz, Antonio Llombart‐Cussac, Emilio Alba, Fernando Moreno, Luís Manso, Silvana Mourón, Rámón Colomer, Javier Cortés, Esther Zamora, María J. Bueno, Cristina Tebar, Encarna Adrover, Noelia Martínez-Jáñez, Raquel Andrés, Desirée Jiménez, Adam Grant
article en
12 citations

Abstract

High MeCo is predictive of poor outcomes in HER2-negative early breast cancer, although this risk can be mitigated by nintedanib, which is able to specifically reduce MeCo.

Clinical Cancer ResearchVol. 30(22)
University of Arizona (US), Catalan Institute for Water Research (ES), Arizona Science Center (US), Hospital Clínico San Carlos (ES), Institut d'Investigació Biomédica de Bellvitge (ES), 490 BioTech (United States) (US), Spanish National Cancer Research Centre (ES), Hospital Clínico Universitario de Valencia (ES), Hospital Universitario 12 De Octubre (ES), MedSIR (Spain) (ES), Institut Català d'Oncologia (ES), Hospital Arnau de Vilanova (ES), Vall d'Hebron Hospital Universitari (ES), Hospital Universitario de La Princesa (ES), Hospital Clínico Universitario Lozano Blesa (ES), Centro de Investigación del Cáncer (ES), CS Diagnostics (DE), Hospital Universitario de Fuenlabrada (ES), Hospital Universitari de Girona Doctor Josep Trueta (ES), Complejo Hospitalario Universitario de Albacete (ES), International Breast Cancer Study Group (CH), Hospital Clínico Universitario Virgen de la Victoria (ES), Hospital Universitario Ramón y Cajal (ES), Vall d'Hebron Institute of Oncology (ES), Universidad Autónoma de Madrid (ES), Universidad Europea de Madrid (ES)
Mary Kay Foundation, Instituto de Salud Carlos III
Good health and well-being
Openalex Percentile: Top 6%
Cellular Mechanics and Interactions
3.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.